Impact of Skeletal Muscle Quality and Loss on the Outcome of Liver Transplantation

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorZhejiang University

About this trial

CT imaging-based skeletal muscle assessment has been found to predict the outcomes of many diseases. Previous evidence revealed that pre-transplant muscle quality and post-transplant muscle loss were associated with transplant outcomes. However, there is no prospective study supporting the aforementioned conclusions. This study aims to prospectively include liver transplant patients from multiple transplant centers, collecting their pre-transplant CT images as well as post-transplant CT images at specific time points. The objective is to further explore and clarify the correlation between skeletal muscle assessment and the prognosis of liver transplant patients. The goal is to provide guidance for peri-transplant health monitoring and disease intervention for liver transplant patients.

Eligibility criteria

Qualifiers

Adult patients undergoing deceased donor liver transplantation (DDLT) for the first time

Disqualifiers

Pediatric transplants

Presence of portal vein tumor thrombus according to imageing before transplantation

Presence of macrovascular invasion according to imageing before transplantation

Re-transplants

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

800 Participants
are grouped into 4 trial groups

Locations

This trial has no locations

Sponsors and collaborators

Zhejiang University

Lead sponsor

First Affiliated Hospital of Zhejiang University

Collaborator

Shulan (Hangzhou) Hospital

Collaborator

The Affiliated Hospital of Qingdao University

Collaborator

West China Hospital

Collaborator

Huashan Hospital

Collaborator